The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
NCT Number: NCT05751200
This is a retrospective study based on the data available in our hospital database for ATAAD patients from January 2020 to December 2021. These patients were divided into two groups according to the surgical procedures of aortic root. This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD.
Looking for future studies?
Notify MeAll sexes
Observational
Xi'an, Shaanxi, 710061, China
Acute type A aortic dissection (ATAAD) is a life-threatening disease with high mortality. Surgery remains the gold standard for the treatment of ATAAD. In recent years, ATAAD is still a persistent challenge for cardiovascular surgeons. This is a retrospective study based on the data available in our hospital database for ATAAD patients undergoing total aortic arch replacement with elephant trunk stent under cryogenic stop circulation from January 2020 to December 2021. These patients were divided into two groups according to the surgical procedures of aortic root: continuous aortic root suture group (CARS group); "aortic root reinforcement combined with vascular grafts eversion and built-in", which was created by our group and to be named as XJ-procedure (XJ-procedure group, XJ is an acronym for Xi'an Jiaotong University). The main outcome was defined as 30-day mortality. Secondary outcomes included the postoperative bleeding necessitating re-operation and the incidence of anastomotic pseudoaneurysm, residual aortic root dissection and severe aortic regurgitation before discharge and at 3 and 6 months after the operation. This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No Intervention.
Time frame: Within 30 days after the surgery
Patients died within 30 days after the surgery. Data were obtained from the medical records.
Time frame: About 2 weeks after the surgery.
Postoperative bleeding necessitated reoperation during hospitalization. Data were obtained from the surgical records and medical records.
Time frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
The occurrence of anastomotic pseudoaneurysm was examined by postoperative computed tomography angiography examination.
Time frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
The occurrence of residual aortic dissection was examined by postoperative computed tomography angiography examination.
Time frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
The occurrence of aortic valve regurgitation greater than grade2+, which was decided by cardiac ultrasonography.
First Affiliated Hospital Xi'an Jiaotong University
Other
Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ ): an Investigator-initiated, Single-center, Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04711889
Acute Aortic Syndrome, Aortic Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04831073
Acute Aortic Syndrome, Aneurysm
Bruges, Belgium
View Trial DetailsNCT06415630
Nomogram, Postoperative Reintubation
Wuhan, Hubei, China
View Trial DetailsNCT05346497
Type A Aortic Dissection
View Trial Details